Læknablaðið

Årgang

Læknablaðið - 01.09.1979, Side 48

Læknablaðið - 01.09.1979, Side 48
192 LÆKNABLAÐIÐ Tom Berganl Antibiotic treatment of patients with reduced renal functions Drugs which are eliminated mainly through the kidneys are subject to a prolonged elimi- nation in patients with reduced renai function. In order to avoid toxic reactions, it is import- ant to adjust the dose. This must be done in such a way, however, that therapeutic efficacy against the infection is maintained. This is achieved by maintaining the same ratio bet- ween dosage interval and serum half-life in all patients, regardless renal function. Prefer- able drugs in renal impairment are penicillins, cehalosporins, macrolides, metronidazole, and, after careful adjustments, aminoglycosides. -— The half-life may be determined in the indivi- dual patient or stipulated temporarily from renal function determined by renal clearance. Serum creatinine determinations are not suffi- cient for assessment of the normalcy of renal function, because the clearance is markedly reduced in ages above 70 years, although the serum creatinine levels are maintained within normal limits. Increased elimination time only starts with renally eliminated drugs when the kidney function is below a glomerular filtra- tion of 30 ml/min. l Departments of Microbiology, Aker sykehus and Institute of Pharmacy, University of Oslo. Ragnarsson, J., M.D., Pohl, M.A., MD., Valenzuela, R., M.D. Gold nephropathy — Resolution of membraneous nephropathy induced by gold therapy A 28-year-old black female with sero positive rheumatoid arthritis developed nephrotic syn- drome following a second course of gold thera- py. SLE and other secondary causes of nephro- tic syndrome were excluded by appropriate laboratory tests. Renal biopsy in March of 1976 demonstrated typical membraneous nephro- pathy with electron dense deposits on electron microscopy. X-ray dispersion analysis docu- mented gold particles in the renal tubular cells and the interstitial macrophages. Follow- ing cessation of goid therapy the nephrotic syndrome resolved and the second renal biopsy fourteen months later showed resolution of the membranecous lesion. The electron micro- scopy showed dramatic resolution of the elee- tron dense deposits in the glomerular base- ment membrane and immunomicroscopy showed much weaker staming of the ímmunogioounns in the basement membrane. Gold was not de- monstrated by X-ray dispersion analysis. In patients with gold nephropathy the prognosis is generally favourable, however, serial renal biopsies are lacking and therefore, histologi- cal resolution of gold induced membraneous lesions have not been previousiy demonstrated. The possible pathogenic mechanisms are revi- ewed, and we speculate that gold leads to release of renal tubuiar cell antigens. These antigens could then lead to the formation of soluable immune complexes that are trapped in the glomerular basement membrane or these renal tubular epitheiial cell antigens could lodge in the glomerular basement membrane and attract circulating antibodies to form an immune complex in the glomerular base- ment membrane. Similar mechamsm has been invoked as the cause of membraneous glome- rulopathy, both in humans and in animal mo- dels. When the gold therapy is stopped and the stimulus for the release of these antigens should disappear and the membraneous de- posits might be expected to resolve. In con- clusion we have described a patient who de- veloped nephrotic syndrome with changes of an immune complex membraneous nephro- pathy following goid therapy. When gold tera- py was discontinued, the clincal nephrotic syndrome disappeared and the renal lesion re- gressed histologically. These observations are consistent with the notion that gold nephropat- hy is an autoiogous immune complex giome- rulopathy induced by the release of renal tubuiar epithelial cell antigen. Sigurður B. Þorsteinsson and Pall Asmundsson Methicillin hypersensitivity-Iike syndrome — Report of five cases Methicillin hypersensitivity-like syndrome is a potentially live threatening complication associated with Methicillin therapy. The syndrome includes any combination of fever, skin, rash, eosinophilia, neutropenia, haema- turia, pyuria, and interstitial nephritis with renal failure of varying severity. The possible pathogenic mechanisms accounting for the renal affection will be briefly discussed. We describe five patients aged 10-67 years with methicillin hypersensitivity, the duration of methicillin treatment varied from 15 to 21 days. The signs of methicillin toxicity ap- peared after 11-14 days of treatment. All had fever and eosinophilia and abnormal urina- lysis. Two patients had skin rash and two developed renal failure, one moderate and

x

Læknablaðið

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.